Modulating intestinal neuroimmune VIPergic signaling attenuates the reduction in ILC3-derived IL-22 and hepatic steatosis in MASLD.

Autor: Nguyen, Henry H., Talbot, Jhimmy, Dayi Li, Raghavan, Varsha, Littman, Dan R.
Zdroj: Hepatology Communications; Nov2024, Vol. 8 Issue 11, p2-12, 11p
Databáze: Complementary Index